+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Estradiol"

Combined Pituitary Hormone Deficiencies Market Report 2024 - Product Thumbnail Image

Combined Pituitary Hormone Deficiencies Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Bioidentical Hormones Global Market Report 2024 - Product Thumbnail Image

Bioidentical Hormones Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Hormone Therapy Market Report 2025 - Product Thumbnail Image

Hormone Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Drugs For Hormonal Replacement Therapy Global Market Report 2024 - Product Thumbnail Image

Drugs For Hormonal Replacement Therapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Male Hypogonadism - Pipeline Insight, 2024 - Product Thumbnail Image

Male Hypogonadism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Central Precocious Puberty - Pipeline Insight, 2024 - Product Thumbnail Image

Central Precocious Puberty - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Postmenopausal Osteoporosis Treatment Market - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Loading Indicator

Estradiol is a hormone used in the treatment of prostate cancer. It is a form of estrogen, and is used to reduce the levels of testosterone in the body, which can help slow the growth of prostate cancer cells. Estradiol is typically administered as an injection, and is often used in combination with other drugs to treat prostate cancer. It is also used to reduce the risk of prostate cancer recurrence after surgery. Side effects of estradiol can include hot flashes, breast tenderness, and increased risk of blood clots. The estradiol market is a growing segment of the prostate cancer drug market. It is used in combination with other drugs to treat prostate cancer, and is increasingly being used to reduce the risk of recurrence after surgery. The market is expected to continue to grow as more patients are diagnosed with prostate cancer and the need for effective treatments increases. Companies in the estradiol market include Pfizer, Novartis, and AstraZeneca. Show Less Read more